Related Experiment Video
Updated: Jul 27, 2026

05:52
Hyponeophagia: A Measure of Anxiety in the Mouse
Published on: May 17, 2011
22.2K
Mice Lacking Gpr75 are Hypophagic and Thin.
David R Powell1, Deon D Doree1, Christopher M DaCosta1
1Department of Pharmaceutical Biology, Lexicon Pharmaceuticals, Inc, The Woodlands, TX, USA.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|January 13, 2022
Summary
Mice lacking GPR75 (Gpr75 knockout) are thin and have improved glucose control. This suggests GPR75 inhibition may reduce body fat and enhance insulin sensitivity in humans.
Area of Science:
- Metabolic research
- Genetics
- Endocrinology
Background:
- G protein-coupled receptor 75 (GPR75) is an orphan receptor.
- Human GPR75 haploinsufficiency is associated with a thin phenotype.
- Gpr75 knockout (KO) mice exhibit reduced body weight and improved glucose homeostasis.
Purpose of the Study:
- Confirm findings of thin phenotype and improved glucose homeostasis in Gpr75 KO mice.
- Investigate the contribution of decreased energy intake versus increased energy expenditure to the thin phenotype.
- Evaluate the role of GPR75 in metabolic regulation.
Main Methods:
- Generation of Gpr75 KO mice via homologous recombination.
- Comparative analysis of Gpr75 KO and wild-type (WT) littermates (female and male).
- Assessment of body composition (DXA, QMR), glucose homeostasis (OGTTs), food intake, energy expenditure, and locomotor activity.
Main Results:
- Gpr75 KO mice exhibited significantly reduced body fat (49% less) and lean body mass (4% less) compared to WT littermates.
- KO mice showed reduced body fat at weaning and became hypophagic post-weaning, with comparable energy expenditure and activity levels.
- Improved glucose tolerance and insulin sensitivity were observed in Gpr75 KO mice, with lower glucose and insulin levels during OGTTs.
Conclusions:
- Gpr75 KO mice present as thin, hypophagic, and exhibit enhanced glucose tolerance and insulin sensitivity.
- These findings support the potential of GPR75 inhibition as a therapeutic strategy for obesity and related metabolic disorders in humans.
- Targeting GPR75 may offer a safe approach to reduce body fat and improve metabolic health.

